branded drugs

Drug Makers Find New Ways to Thwart Generic Competition
Drug Makers Find New Ways to Thwart Generic CompetitionBrand-name drug companies are finding creative ways to extend patent protection, causing patient access problems.
Study: Early-term births linked to poorer CRF through young adulthoodLongitudinal data from a prospective cohort study indicate that being born early term may negatively affect a child’s cardiorespiratory fitness. Plus: Is there a difference in PTB rate between branded and compounded 17P? Also, a review analyzes whether or not there are any benefits to placentophagy.
Aggressive price growth pushes healthcare spending upRise in use of outpatient care and professional services contributed to quicker growth in spending for the privately insured over previous years.
Global generics drug market to grow 10% annuallyPatents expire, competition rises, and outsourcing expands.
New bill aims to support generic, biosimilar drug competitionThe CREATES Act came about because some pharmaceutical manufacturers are misusing the REMS program to prevent generic drug development.
Patients, payers, and manufacturers’ drug couponsAccording to PBMs, those drug coupons are something else.
The antisubstitution controversy: Going strong in '72
The antisubstitution controversy: Going strong in '72Nowadays, we think of generics as economical options. Not so long ago, plenty of folks thought of them as sacrilege.
Top 7 new facts about drug spendingAs organizations and politicians continue to sound the alarm that drug prices are rising, another new report confirmed the trend. Total spending on medicines in the US reached $310 billion in 2015 on an estimated net price basis, up 8.5 percent from the previous year, according to a new report from the IMS Institute for Healthcare Informatics.
The effect of drug pricing on cataract surgeryIn a recent wave of drug price increases that can only be explained by pharmaceutical manufacturers’ desire for profit maximization and which doctors and patients may call price gouging, the drug price war has been brought to the doorsteps of many eyecare providers. As optometrists are increasing their practice of medical optometry, patients are now calling their doctors about prior authorizations and unaffordable drug copays.
Are your prior auth provisions stifling medication adherence?Prior authorizations are here to stay. Are yours working against you? Find out.